According to Infomed, nearly three years after the Covid-19 pandemic, the emergence of severe acute hepatitis of unknown etiology, mpox, Ebola outbreaks, the confluence of Covid-19, influenza and respiratory syncytial virus has been observed in some countries.

In this context, dengue has recovered the figures reported before the pandemic. Only in the Americas and according to the Pan American Health Organization (PAHO), as many as 2,552,892 cases had been reported, of which 4,104 were severe and 1,177 died.

The 4 dengue serotypes continue to circulate. It is also observed the gradual increase of chikungunya and to a lesser degree of zika. Finally, the reports of cases of Mayaro and Oropouche are becoming more frequent.

The course will offer a room for updating and discussing the epidemiological situation and advances in the knowledge, prevention and control of Dengue and other arboviral diseases with special reference to Chikungunya, Zika, Yellow Fever, Mayaro and Oropouche.

Issues of interest are the patient clinical management, vector control, integrated surveillance, advances in pathogenesis research, vaccines, human, viruses and vector genetics, new control tools, the influence of climate change. New international initiatives and their impact on the arbovirus disease control will be shared.

According to the call, the course aims to enable physicians, virologists, immunologists, sociologists, epidemiologists, entomologists, health administrators, alongside professors from prestigious national and international institutions, to discuss the most relevant and current aspects of various diseases transmitted by Aedes aegypti.

pll/rgh/crc